Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 1/2 3Phase 2 2Phase NA 1Phase 3 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 433Neoplasms 371Prostatic Neoplasms 206Lung Neoplasms 195Colorectal Neoplasms 151Motor Activity 94Uterine Cervical Neoplasms 83Pancreatic Neoplasms 78Carcinoma, Non-Small-Cell Lung 75Head and Neck Neoplasms 74Brain Neoplasms 69Ovarian Neoplasms 65Carcinoma, Hepatocellular 53Colonic Neoplasms 51Rectal Neoplasms 50Neoplasm Metastasis 50Anxiety Disorders 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Glioblastoma 43Hematologic Neoplasms 42Depression 41Melanoma 37Glioma 37Disease 37Stomach Neoplasms 35Sarcoma 35Multiple Myeloma 34Pain 32Carcinoma, Renal Cell 32Lymphoma 31

Interventions

Radiotherapy, Intensity-Modulated 1Phantoms, Imaging 1Magnetic Resonance Spectroscopy 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Epstein-Barr Virus Infections × 90 days × Clear all
NCT06682442 2026-05-01

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

University of California, San Francisco

Phase NA Recruiting
66 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡